A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Clinical trial NCT06835569 · RECRUITING

Trial details

NCT number: NCT06835569
Sponsor: Alterome Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer PDAC - Pancreatic Ductal Adenocarcinoma NSCLC (Non-small Cell Lung Cancer)CRC (Colorectal Cancer)Advanced Solid Tumors

Start date: 2025-03-05
Primary completion: 2029-05-01
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.